These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30190373)

  • 1. Endoglycosidase S Enables a Highly Simplified Clinical Chemistry Procedure for Direct Assessment of Serum IgG Undergalactosylation in Chronic Inflammatory Disease.
    Vanderschaeghe D; Meuris L; Raes T; Grootaert H; Van Hecke A; Verhelst X; Van de Velde F; Lapauw B; Van Vlierberghe H; Callewaert N
    Mol Cell Proteomics; 2018 Dec; 17(12):2508-2517. PubMed ID: 30190373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?
    Lood C; Allhorn M; Lood R; Gullstrand B; Olin AI; Rönnblom L; Truedsson L; Collin M; Bengtsson AA
    Arthritis Rheum; 2012 Aug; 64(8):2698-706. PubMed ID: 22392566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugar-free antibodies--the bacterial solution to autoimmunity?
    Allhorn M; Collin M
    Ann N Y Acad Sci; 2009 Sep; 1173():664-9. PubMed ID: 19758213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant suppression of inflammation by glycan-hydrolyzed IgG.
    Nandakumar KS; Collin M; Happonen KE; Croxford AM; Lundström SL; Zubarev RA; Rowley MJ; Blom AM; Holmdahl R
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10252-7. PubMed ID: 23671108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
    J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.
    Dixon EV; Claridge JK; Harvey DJ; Baruah K; Yu X; Vesiljevic S; Mattick S; Pritchard LK; Krishna B; Scanlan CN; Schnell JR; Higgins MK; Zitzmann N; Crispin M
    J Biol Chem; 2014 May; 289(20):13876-89. PubMed ID: 24668806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.
    Albert H; Collin M; Dudziak D; Ravetch JV; Nimmerjahn F
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15005-9. PubMed ID: 18815375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis.
    Allhorn M; Olin AI; Nimmerjahn F; Collin M
    PLoS One; 2008 Jan; 3(1):e1413. PubMed ID: 18183294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.
    Collin M; Olsén A
    EMBO J; 2001 Jun; 20(12):3046-55. PubMed ID: 11406581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein.
    Sjögren J; Struwe WB; Cosgrave EF; Rudd PM; Stervander M; Allhorn M; Hollands A; Nizet V; Collin M
    Biochem J; 2013 Oct; 455(1):107-18. PubMed ID: 23865566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-liquid diffusion crystallization improves the X-ray diffraction of EndoS, an endo-β-N-acetylglucosaminidase from Streptococcus pyogenes with activity on human IgG.
    Trastoy B; Lomino JV; Wang LX; Sundberg EJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1405-10. PubMed ID: 24316841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
    Allhorn M; Olsén A; Collin M
    BMC Microbiol; 2008 Jan; 8():3. PubMed ID: 18182097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis.
    Nandakumar KS; Collin M; Olsén A; Nimmerjahn F; Blom AM; Ravetch JV; Holmdahl R
    Eur J Immunol; 2007 Oct; 37(10):2973-82. PubMed ID: 17899548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.
    Du JJ; Klontz EH; Guerin ME; Trastoy B; Sundberg EJ
    Glycobiology; 2020 Mar; 30(4):268-279. PubMed ID: 31172182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On enzymatic remodeling of IgG glycosylation; unique tools with broad applications.
    Sjögren J; Lood R; Nägeli A
    Glycobiology; 2020 Mar; 30(4):254-267. PubMed ID: 31616919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.
    Trastoy B; Lomino JV; Pierce BG; Carter LG; Günther S; Giddens JP; Snyder GA; Weiss TM; Weng Z; Wang LX; Sundberg EJ
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6714-9. PubMed ID: 24753590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IgG-specific endoglycosidases EndoS and EndoS2 are distinguished by conformation and antibody recognition.
    Sudol ASL; Crispin M; Tews I
    J Biol Chem; 2024 May; 300(5):107245. PubMed ID: 38569940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions.
    Baruah K; Bowden TA; Krishna BA; Dwek RA; Crispin M; Scanlan CN
    J Mol Biol; 2012 Jun; 420(1-2):1-7. PubMed ID: 22484364
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Naegeli A; Bratanis E; Karlsson C; Shannon O; Kalluru R; Linder A; Malmström J; Collin M
    J Exp Med; 2019 Jul; 216(7):1615-1629. PubMed ID: 31092533
    [No Abstract]   [Full Text] [Related]  

  • 20. EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.
    Sjögren J; Cosgrave EF; Allhorn M; Nordgren M; Björk S; Olsson F; Fredriksson S; Collin M
    Glycobiology; 2015 Oct; 25(10):1053-63. PubMed ID: 26156869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.